" class="no-js "lang="en-US"> Naobios - Medtech Alert
Saturday, December 14, 2024
Naobios | Pharmtech Focus

Naobios

About Naobios

Naobios

Naobios provides bioprocess development and contract manufacturing services for viral vaccines and viral vectors. The company was acquired by Clean Biologics on March 1st, 2019 and now supports clients for process development and the manufacture of preclinical and clinical batches.

Related Story

Naobios Delivers Flugen Inc’s M2SR Influenza Vaccine Candidate for Upcoming Clinical Trials

June 22 2022

Naobios, a CDMO (Contract Development and Manufacturing Organization) providing bioprocess development and GMP production of […]

Naobios Manufactures FluGen Inc’s M2SR Influenza Vaccine Candidate for Upcoming Clinical Trials

September 21 2021

Naobios, a CDMO (Contract Development and Manufacturing Organization) providing bioprocess development and GMP production of […]